Professional Summary
Professional Overview
Michael Wood is a seasoned pharmaceutical executive and academic leader with a strong track record of driving innovation and impact in the life sciences industry. As the Senior Vice President at MapLight Therapeutics, Inc., he leverages his deep expertise in pharmacology and neuroscience to guide the company's strategic initiatives and product development efforts. Concurrently, he serves as an Adjunct Professor at Drexel University College of Medicine, where he shares his expertise with the next generation of industry leaders.
Experience Summary
Current Role
As the Senior Vice President at MapLight Therapeutics, Inc., Michael is responsible for overseeing the company's research and development activities, leading cross-functional teams, and driving the advancement of the organization's therapeutic pipeline. Under his leadership, the company has made significant strides in the development of novel treatments for neurological disorders, showcasing his ability to translate scientific insights into tangible business outcomes.
In addition to his role at MapLight, Michael serves as a Scientific Advisory Board member at Estrigenix Therapeutics, Inc., where he provides strategic guidance and technical expertise to support the company's efforts in women's health. He also holds an Advising Board position at Neurovation Labs, Inc., drawing on his extensive experience in the field of neuroscience to help shape the organization's innovation agenda.
Career Progression
Prior to his current roles, Michael founded Neupharm LLC, a boutique consultancy firm that specialized in providing strategic and technical advisory services to biotechnology and pharmaceutical companies. In this capacity, he leveraged his deep understanding of drug development, regulatory processes, and market dynamics to help clients navigate complex industry challenges and achieve their business objectives.
Earlier in his career, Michael held research and development positions at several leading pharmaceutical companies, where he contributed to the advancement of novel therapeutic approaches and the successful commercialization of multiple products.
Academic Background
Michael holds a Ph.D. in Pharmacology and Physiology from the University of Pennsylvania, where his research focused on the development of novel neuromodulatory therapies. He has authored numerous peer-reviewed publications and has been recognized for his contributions to the scientific community.
Areas of Expertise
- Pharmacology and drug development
- Neuroscience and neurological disorders
- Translational research and clinical trial design
- Strategic planning and business development
- Cross-functional team leadership and collaboration
Professional Impact
Throughout his career, Michael has demonstrated a strong commitment to advancing the field of life sciences and improving patient outcomes. His scientific expertise, coupled with his business acumen, has enabled him to drive meaningful progress in the development of innovative therapeutic solutions.
As a respected industry thought leader, Michael has been invited to speak at various conferences and symposia, sharing his insights and contributing to the broader dialogue on the future of pharmaceutical innovation.
Conclusion
With his extensive experience, deep scientific knowledge, and proven leadership abilities, Michael Wood is well-positioned to continue making significant contributions to the life sciences industry. As he remains focused on advancing the work of MapLight Therapeutics and his other advisory roles, he is poised to drive further advancements in the treatment of neurological and women's health conditions, ultimately enhancing the lives of patients worldwide.
